Commentary: Biologics for psoriasis: steps to heaven 17
- PMID: 23013314
- DOI: 10.1111/bjd.12026
Commentary: Biologics for psoriasis: steps to heaven 17
Comment on
-
Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.Br J Dermatol. 2012 Oct;167(4):710-3; discussion 714-5. doi: 10.1111/bjd.12025. Br J Dermatol. 2012. PMID: 23013312
Publication types
LinkOut - more resources
Full Text Sources
